Labs & Diagnostics Archives - Global Pharma Times

Zeon Lifesciences forays into the B2C segment with the introduction of a range of nutraceutical products

Funding alert: Better Juice Raises $8 Million in Seed Funding

Anti-parasitic drug investigated as potential COVID treatment

AstraZeneca’s lung cancer treatment approved in China

Global Pharma Times

24 June 2021, Thursday

Apollo Diagnostics Launched Drive-Through Covid-19 Testing At NSG IT Park, Aundh, Pune

Staff Reporter

May 3, 2021May 3, 2021

Pune: With the sudden surge of COVID cases during the second wave, the infrastructure pertaining to testing has come under heavy pressure. With an objective to reach...

Metropolis Healthcare wins GOLD Award in two categories at India Health and Wellness Award 2020

Staff Reporter

January 12, 2021January 12, 2021

Metropolis Healthcare Ltd, India’s leading and renowned diagnostic company, has won two gold awards at India Health and Wellness Award 2020. The categories were COVID...

A pilot study reveals low blood sugar at birth and genetic diseases, are important underlying cause for a common form of epilepsy in young Indian children

Staff Reporter

December 16, 2020December 16, 2020

In a first-of-its-kind Medgenome Labs, a genomics and clinical data driven diagnostics and drug discovery research company conducted a study in partnership with doctors from...

Sakra World Hospital Launches World’s First Fully Active Robotic Knee Replacement System

Staff Reporter

December 15, 2020December 15, 2020

Cuvis Joint, Active Robotics Knee Replacement System. Sakra World Hospital, one of the leading healthcare providers in Bengaluru and India’s first FDI hospital now boasts...

Clinical and genetic features of cardiomyopathy reported from multiple large familial cases in India

Staff Reporter

November 28, 2020November 28, 2020

Hypertrophic cardiomyopathy (HCM) affects the health of the heart muscle. Genetic cause of 40-50% of HCM are not known. The mutations responsible for HCM often...

Metropolis Healthcare wins the ‘Diagnostic Company of the Year Award’ organized by Frost & Sullivan

Staff Reporter

November 9, 2020November 9, 2020

India’s leading diagnostic company, Metropolis Healthcare Ltd, has been named Company of the Year in the Indian diagnostic services industry by Frost & Sullivan. ...

Molecular testing is redefining accuracy & time to diagnose Sepsis

Staff Reporter

September 21, 2020September 21, 2020

Sepsis is a serious medical condition that arises when the body’s own response to infection can lead to tissue damage, organ failure and death particularly...

Metropolis’ eighth lab gets Covid-19 testing approval: Testing underway in Coimbatore

Staff Reporter

September 17, 2020September 17, 2020

With an aim to provide end-to-end testing solutions, one of India’s leading and renowned diagnostic companies, Metropolis Healthcare Ltd has begun testing for Covid-19 in...

Cipla and Stempeutics collaborate for launch of Stempeucel®, first ‘Made in India’ Cell Therapy to treat Critical Limb Ischemia (CLI)

Trade News Network

August 25, 2020

Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) referred to as "Cipla" today announced that its partner Stempeutics Research Pvt. Ltd has received regulatory approval by the...

Cipla and Stempeutics collaborate for launch of Stempeucel®, first ‘Made in India’ Cell Therapy to treat Critical Limb Ischemia (CLI)

Trade News Network

August 25, 2020

Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) referred to as "Cipla" today announced that its partner Stempeutics Research Pvt. Ltd has received regulatory approval by the...

Breaking News

Novartis announce digital collaboration with HPE

Kite’s leukaemia cell therapy application validated by EMA

AstraZeneca’s Lynparza for prostate cancer approved in China

Survey reveals over 2 million people impacted by long COVID in UK

MHRA and EC approve Leo Pharma’s Adtralza for atopic dermatitis

Catalent to Acquire RheinCell Therapeutics, Strengthening a Path…

Zeon Lifesciences forays into the B2C segment with the introduction of a range of nutraceutical products

Funding alert: Better Juice Raises $8 Million in Seed Funding

Anti-parasitic drug investigated as potential COVID treatment

AstraZeneca’s lung cancer treatment approved in China

Apollo Diagnostics Launched Drive-Through Covid-19 Testing At NSG IT Park, Aundh, Pune

Metropolis Healthcare wins GOLD Award in two categories at India Health and Wellness Award 2020

A pilot study reveals low blood sugar at birth and genetic diseases, are important underlying cause for a common form of epilepsy in young Indian children

Sakra World Hospital Launches World’s First Fully Active Robotic Knee Replacement System

Clinical and genetic features of cardiomyopathy reported from multiple large familial cases in India

Metropolis Healthcare wins the ‘Diagnostic Company of the Year Award’ organized by Frost & Sullivan

Molecular testing is redefining accuracy & time to diagnose Sepsis

Metropolis’ eighth lab gets Covid-19 testing approval: Testing underway in Coimbatore

Cipla and Stempeutics collaborate for launch of Stempeucel®, first ‘Made in India’ Cell Therapy to treat Critical Limb Ischemia (CLI)

Cipla and Stempeutics collaborate for launch of Stempeucel®, first ‘Made in India’ Cell Therapy to treat Critical Limb Ischemia (CLI)